Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/0221 : 42PR Newswire (US)Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2024/06/0221 : 41GlobeNewswire Inc.NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCsNASDAQ:NVDANVIDIA Corporation
2024/06/0221 : 35GlobeNewswire Inc.Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial RevolutionNASDAQ:NVDANVIDIA Corporation
2024/06/0221 : 32GlobeNewswire Inc.NVIDIA Supercharges Ethernet Networking for Generative AINASDAQ:NVDANVIDIA Corporation
2024/06/0221 : 30Business WireDenodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
2024/06/0221 : 30Business WireDenodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
2024/06/0221 : 30PR Newswire (US)Vention to democratize industrial automation using NVIDIA AI technologies
2024/06/0221 : 30PR Newswire (US)Crimson Cup Coffee & Tea Publishes 2024 Guide on How to Start a Coffee Shop in California
2024/06/0221 : 30PR Newswire (Canada)Vention to democratize industrial automation using NVIDIA AI technologies
2024/06/0221 : 30PR Newswire (Canada)Message de la gouverneure générale et commandante en chef du Canada à l'occasion de la Journée des Forces armées canadiennes
2024/06/0221 : 30PR Newswire (Canada)Message from the Governor General and Commander-in-Chief of Canada on Canadian Armed Forces Day
2024/06/0221 : 13GlobeNewswire Inc.NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI DevelopersNASDAQ:NVDANVIDIA Corporation
2024/06/0221 : 11GlobeNewswire Inc.NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI AvatarsNASDAQ:NVDANVIDIA Corporation
2024/06/0221 : 05Business WireIMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placeboNASDAQ:AZNAstraZeneca PLC
2024/06/0221 : 00Business WireENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapyNASDAQ:AZNAstraZeneca PLC
2024/06/0221 : 00GlobeNewswire Inc.CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
2024/06/0221 : 00Business WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
2024/06/0221 : 00GlobeNewswire Inc.Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)NASDAQ:NTLAIntellia Therapeutics Inc
2024/06/0221 : 00Business WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNYSE:RCUSArcus Biosciences Inc
2024/06/0221 : 00Business WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
2024/06/0221 : 00GlobeNewswire Inc.William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
2024/06/0221 : 00Business WireMassive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
2024/06/0221 : 00Business WireENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
2024/06/0221 : 00Business WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNYSE:RCUSArcus Biosciences Inc
2024/06/0221 : 00PR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
2024/06/0220 : 45The Daily Hodl‘Hundreds of Trillions’– Sergey Nazarov Says 2024 Is Year Crypto and Global Financial System MergeCOIN:FETUSDFetch
2024/06/0220 : 20PR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/
2024/06/0220 : 20PR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024/
2024/06/0220 : 00Business WireJune Joy at Juicy Stakes Casino
2024/06/0220 : 00PR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024/